Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 588,378 | reported | 02 Feb 2026 | tx 5+460,000−69,772 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 16,846 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 25,382 | 1.39 USD | |
| 02 Feb 2026 | SALE | Akebia Therapeutics, Inc. | 27,544 | 1.39 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 190,000 | 0.00 USD | |
| 30 Jan 2026 | GRANT_AWARD | Akebia Therapeutics, Inc. | 270,000 | 0.00 USD | deriv |